Table S1.
Doxorubicin-induced transcriptome data used in the study: cancer type, cell line, GEO accession numbers of the control and case gene expression data
| Cancer type | Cell Line | GEO control | GEO case |
|---|---|---|---|
| Renal cancer | 786-0 |
GSM3233605 GSM3233606 GSM3233607 |
GSM3233608 GSM3233609 GSM3233610 |
| Breast cancer | MCF7 |
GSM3233810 GSM3233811 GSM3233812 |
GSM3233815* GSM3233816* GSM3233817* |
| Leukemia | CCRF-CEM |
GSM3233659 GSM3233660 GSM3233661 |
GSM3233662 GSM3233663 GSM3233664 |
| Non-small cell lung cancer | A549/ATCC |
GSM3233623 GSM3233624 GSM3233625 |
GSM3233626 GSM3233627 GSM3233628 |
| Colon cancer | COLO 205 |
GSM3233668 GSM3233669 GSM3233670 |
GSM3233671 GSM3233672 GSM3233673 |
*
100 nm of doxorubicin was administered.